ZUMWALT LEANNE M 4
4 · Akebia Therapeutics, Inc. · Filed Feb 18, 2021
Insider Transaction Report
Form 4
ZUMWALT LEANNE M
Director
Transactions
- Award
Stock Option (Right to buy)
2021-02-16+80,200→ 80,200 totalExercise: $4.87Exp: 2031-02-16→ Common Stock (80,200 underlying)
Footnotes (1)
- [F1]The options will vest over three years: 33 1/3 % of the options will vest on the first anniversary of the grant date and the remaining 66 2/3 % will vest ratably on the first day of each calendar quarter thereafter.